Acquiring Company
Korsana Biosciences
Acquired Company
Korsana Biosciences
WalthamWalthamBiotechnologyHealthcareHealth CareTherapeuticsBiotechnologyHealthcareHealth CareTherapeuticsDescription
Cyclerion Therapeutics and Korsana Biosciences have entered into a definitive merger agreement to combine their operations. The new entity will operate under the name Korsana Biosciences, aiming to advance therapies for neurodegenerative diseases. The merger involves an all-stock transaction with a concurrent private financing of approximately $380 million. The combined company plans to maintain operations into 2029.
Who to call at Korsana Biosciences, and when
When Korsana Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Korsana Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Korsana Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Korsana Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Korsana Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Korsana Biosciences?
Korsana Biosciences was acquired by Korsana Biosciences, based in Waltham. The deal was reported on April 1, 2026. Korsana Biosciences, Inc. is a biotechnology company focused on discovering and developing novel therapies for neurodegenerative diseases, particularly Alzheimer's disease. Korsana Biosciences is publicly traded (KRSA) and operates in Biotechnology.
When did Korsana Biosciences acquire Korsana Biosciences?
Korsana Biosciences's acquisition of Korsana Biosciences was reported on April 1, 2026. Cyclerion Therapeutics and Korsana Biosciences have entered into a definitive merger agreement to combine their operations. The new entity will operate under the name Korsana Biosciences, aiming to advance therapies for neurodegenerative diseases. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Korsana Biosciences do?
Korsana Biosciences, Inc. is a biotechnology company focused on discovering and developing novel therapies for neurodegenerative diseases, particularly Alzheimer's disease. It is publicly traded (KRSA), operating in Biotechnology, and is based in Waltham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.